ReviewThe AAPS journal2023

Biopharmaceutics Risk Assessment-Connecting Critical Bioavailability Attributes with In Vitro, In Vivo Properties and Physiologically Based Biopharmaceutics Modeling to Enable Generic Regulatory Submissions.

Tausif Ahmed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.